Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers

10.1371/journal.pone.0036115

Saved in:

Bibliographic Details
Main Authors:	Yiu K.H., Atsma D.E., Delgado V., Ng A.C.T., Witkowski T.G., Ewe S.H., Auger D., Holman E.R., van Mil A.M., Breuning M.H., Tse H.F., Bax J.J., Schalij M.J., Marsan N.A.
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	2019
Subjects:	angiotensin receptor antagonist beta adrenergic receptor blocking agent calcium channel blocking agent dipeptidyl carboxypeptidase inhibitor diuretic agent myosin binding protein C adult article calibration cardiovascular risk clinical article controlled study coronary artery disease diabetes mellitus electrocardiogram female gene mutation heart ejection fraction heart infarction heart left ventricle heart muscle heart muscle revascularization heart ventricle wall motion heterozygote detection human hyperlipidemia hypertension hypertrophic cardiomyopathy kidney dysfunction male phenotype protein expression reproducibility sensitivity and specificity smoking systolic dysfunction echocardiography echography genetics heterozygote middle aged mutation pathology pathophysiology physiology prognosis systole Adult Cardiomyopathy, Hypertrophic Echocardiography Female Heterozygote Humans Male Middle Aged Mutation Myocardium Phenotype Prognosis Reproducibility of Results Systole
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/161984
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-161984
record_format	dspace
spelling	sg-nus-scholar.10635-1619842023-11-01T07:40:37Z Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers Yiu K.H. Atsma D.E. Delgado V. Ng A.C.T. Witkowski T.G. Ewe S.H. Auger D. Holman E.R. van Mil A.M. Breuning M.H. Tse H.F. Bax J.J. Schalij M.J. Marsan N.A. DUKE-NUS MEDICAL SCHOOL angiotensin receptor antagonist beta adrenergic receptor blocking agent calcium channel blocking agent dipeptidyl carboxypeptidase inhibitor diuretic agent myosin binding protein C adult article calibration cardiovascular risk clinical article controlled study coronary artery disease diabetes mellitus electrocardiogram female gene mutation heart ejection fraction heart infarction heart left ventricle heart muscle heart muscle revascularization heart ventricle wall motion heterozygote detection human hyperlipidemia hypertension hypertrophic cardiomyopathy kidney dysfunction male phenotype protein expression reproducibility sensitivity and specificity smoking systolic dysfunction echocardiography echography genetics heterozygote hypertrophic cardiomyopathy middle aged mutation pathology pathophysiology physiology prognosis systole Adult Cardiomyopathy, Hypertrophic Echocardiography Female Heterozygote Humans Male Middle Aged Mutation Myocardium Phenotype Prognosis Reproducibility of Results Systole 10.1371/journal.pone.0036115 PLoS ONE 7 5 e36115 2019-11-11T06:39:48Z 2019-11-11T06:39:48Z 2012 Article Yiu K.H., Atsma D.E., Delgado V., Ng A.C.T., Witkowski T.G., Ewe S.H., Auger D., Holman E.R., van Mil A.M., Breuning M.H., Tse H.F., Bax J.J., Schalij M.J., Marsan N.A. (2012). Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers. PLoS ONE 7 (5) : e36115. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0036115 19326203 https://scholarbank.nus.edu.sg/handle/10635/161984 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20191101
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	angiotensin receptor antagonist beta adrenergic receptor blocking agent calcium channel blocking agent dipeptidyl carboxypeptidase inhibitor diuretic agent myosin binding protein C adult article calibration cardiovascular risk clinical article controlled study coronary artery disease diabetes mellitus electrocardiogram female gene mutation heart ejection fraction heart infarction heart left ventricle heart muscle heart muscle revascularization heart ventricle wall motion heterozygote detection human hyperlipidemia hypertension hypertrophic cardiomyopathy kidney dysfunction male phenotype protein expression reproducibility sensitivity and specificity smoking systolic dysfunction echocardiography echography genetics heterozygote hypertrophic cardiomyopathy middle aged mutation pathology pathophysiology physiology prognosis systole Adult Cardiomyopathy, Hypertrophic Echocardiography Female Heterozygote Humans Male Middle Aged Mutation Myocardium Phenotype Prognosis Reproducibility of Results Systole
spellingShingle	angiotensin receptor antagonist beta adrenergic receptor blocking agent calcium channel blocking agent dipeptidyl carboxypeptidase inhibitor diuretic agent myosin binding protein C adult article calibration cardiovascular risk clinical article controlled study coronary artery disease diabetes mellitus electrocardiogram female gene mutation heart ejection fraction heart infarction heart left ventricle heart muscle heart muscle revascularization heart ventricle wall motion heterozygote detection human hyperlipidemia hypertension hypertrophic cardiomyopathy kidney dysfunction male phenotype protein expression reproducibility sensitivity and specificity smoking systolic dysfunction echocardiography echography genetics heterozygote hypertrophic cardiomyopathy middle aged mutation pathology pathophysiology physiology prognosis systole Adult Cardiomyopathy, Hypertrophic Echocardiography Female Heterozygote Humans Male Middle Aged Mutation Myocardium Phenotype Prognosis Reproducibility of Results Systole Yiu K.H. Atsma D.E. Delgado V. Ng A.C.T. Witkowski T.G. Ewe S.H. Auger D. Holman E.R. van Mil A.M. Breuning M.H. Tse H.F. Bax J.J. Schalij M.J. Marsan N.A. Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers
description	10.1371/journal.pone.0036115
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Yiu K.H. Atsma D.E. Delgado V. Ng A.C.T. Witkowski T.G. Ewe S.H. Auger D. Holman E.R. van Mil A.M. Breuning M.H. Tse H.F. Bax J.J. Schalij M.J. Marsan N.A.
format	Article
author	Yiu K.H. Atsma D.E. Delgado V. Ng A.C.T. Witkowski T.G. Ewe S.H. Auger D. Holman E.R. van Mil A.M. Breuning M.H. Tse H.F. Bax J.J. Schalij M.J. Marsan N.A.
author_sort	Yiu K.H.
title	Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers
title_short	Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers
title_full	Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers
title_fullStr	Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers
title_full_unstemmed	Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers
title_sort	myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers
publishDate	2019
url	https://scholarbank.nus.edu.sg/handle/10635/161984
_version_	1781791872684916736

Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers

Similar Items